Physician profile
Melissa Andersen
NPI 1194464909
$1,574.53
in general payments reported to CMS, 2019-2025
15 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $443 · 2024: $750 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.54 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $303.11 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $269.18 | 2023-2025 | Lokelma, Brilinta, Wainua |
| Merck Sharp & Dohme LLC | $183.36 | 2023-2025 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $170.22 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.57 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $140.45 | 2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.27 | 2023-2024 | Lifevest |
| Boston Scientific Corporation | $53.28 | 2023 | Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device, Ingevity+ |
| Scpharmaceuticals INC. | $51.24 | 2024-2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $48.98 | 2023 | Arcalyst |
| Cvrx, INC. | $45.10 | 2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $27.96 | 2023 | |
| Medtronic, INC. | $19.57 | 2024 | Mycarelink |
| Esperion Therapeutics, INC. | $19.04 | 2025 | Nexletol |
| Novo Nordisk INC | $16.20 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.